285 related articles for article (PubMed ID: 8081532)
1. Prenatal drug use in Minneapolis-St Paul, Minn. A 4-year trend.
Yawn BP; Thompson LR; Lupo VR; Googins MK; Yawn RA
Arch Fam Med; 1994 Jun; 3(6):520-7. PubMed ID: 8081532
[TBL] [Abstract][Full Text] [Related]
2. Assessment of exposure to opiates and cocaine during pregnancy in a Mediterranean city: preliminary results of the "Meconium Project".
Pichini S; Puig C; Zuccaro P; Marchei E; Pellegrini M; Murillo J; Vall O; Pacifici R; García-Algar O
Forensic Sci Int; 2005 Oct; 153(1):59-65. PubMed ID: 15923097
[TBL] [Abstract][Full Text] [Related]
3. Substance use in rural Midwestern pregnant women.
Yawn BP; Yawn RA; Uden DL
Arch Fam Med; 1992 Sep; 1(1):83-8. PubMed ID: 1341592
[TBL] [Abstract][Full Text] [Related]
4. Drug screening of newborns by meconium analysis: a large-scale, prospective, epidemiologic study.
Ostrea EM; Brady M; Gause S; Raymundo AL; Stevens M
Pediatrics; 1992 Jan; 89(1):107-13. PubMed ID: 1727992
[TBL] [Abstract][Full Text] [Related]
5. Meconium testing for cocaine metabolite: prevalence, perceptions, and pitfalls.
Rosengren SS; Longobucco DB; Bernstein BA; Fishman S; Cooke E; Boctor F; Lewis SC
Am J Obstet Gynecol; 1993 May; 168(5):1449-56. PubMed ID: 8498426
[TBL] [Abstract][Full Text] [Related]
6. The Maternal Lifestyle Study: drug use by meconium toxicology and maternal self-report.
Lester BM; ElSohly M; Wright LL; Smeriglio VL; Verter J; Bauer CR; Shankaran S; Bada HS; Walls HH; Huestis MA; Finnegan LP; Maza PL
Pediatrics; 2001 Feb; 107(2):309-17. PubMed ID: 11158464
[TBL] [Abstract][Full Text] [Related]
7. Substance use in HIV-Infected women during pregnancy: self-report versus meconium analysis.
Tassiopoulos K; Read JS; Brogly S; Rich K; Lester B; Spector SA; Yogev R; Seage GR
AIDS Behav; 2010 Dec; 14(6):1269-78. PubMed ID: 20532607
[TBL] [Abstract][Full Text] [Related]
8. A comparison of meconium, maternal urine and neonatal urine for detection of maternal drug use during pregnancy.
Wingert WE; Feldman MS; Kim MH; Noble L; Hand I; Yoon JJ
J Forensic Sci; 1994 Jan; 39(1):150-8. PubMed ID: 8113697
[TBL] [Abstract][Full Text] [Related]
9. Neonatal outcome in infants with evidence of fetal exposure to opiates, cocaine, and cannabinoids.
Nair P; Rothblum S; Hebel R
Clin Pediatr (Phila); 1994 May; 33(5):280-5. PubMed ID: 8050257
[TBL] [Abstract][Full Text] [Related]
10. Drug screening in newborns and mothers using meconium samples, paired urine samples, and interviews.
Bibb KW; Stewart DL; Walker JR; Cook VD; Wagener RE
J Perinatol; 1995; 15(3):199-202. PubMed ID: 7666268
[TBL] [Abstract][Full Text] [Related]
11. Prenatal methadone exposure, meconium biomarker concentrations and neonatal abstinence syndrome.
Gray TR; Choo RE; Concheiro M; Williams E; Elko A; Jansson LM; Jones HE; Huestis MA
Addiction; 2010 Dec; 105(12):2151-9. PubMed ID: 20854338
[TBL] [Abstract][Full Text] [Related]
12. The maternal lifestyle study: effects of substance exposure during pregnancy on neurodevelopmental outcome in 1-month-old infants.
Lester BM; Tronick EZ; LaGasse L; Seifer R; Bauer CR; Shankaran S; Bada HS; Wright LL; Smeriglio VL; Lu J; Finnegan LP; Maza PL
Pediatrics; 2002 Dec; 110(6):1182-92. PubMed ID: 12456917
[TBL] [Abstract][Full Text] [Related]
13. Multiple birth concordance of street drug assays of meconium analysis.
Lewis D; Moore C; Leikin JB; Kechavarz L
Vet Hum Toxicol; 1995 Aug; 37(4):318-9. PubMed ID: 8540217
[TBL] [Abstract][Full Text] [Related]
14. Maternal marijuana use, adverse pregnancy outcomes, and neonatal morbidity.
Metz TD; Allshouse AA; Hogue CJ; Goldenberg RL; Dudley DJ; Varner MW; Conway DL; Saade GR; Silver RM
Am J Obstet Gynecol; 2017 Oct; 217(4):478.e1-478.e8. PubMed ID: 28578174
[TBL] [Abstract][Full Text] [Related]
15. [Pregnant women and mothers using alcohol, tobacco and illegal drugs].
Nechanská B; Mravčík V; Sopko B; Velebil P
Ceska Gynekol; 2012 Oct; 77(5):457-69. PubMed ID: 23116352
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Biological Screening and Diagnostic Indicators to Detect In Utero Opiate and Cocaine Exposure Among Mother-Infant Dyads.
Stabler M; Giacobbi P; Chertok I; Long L; Cottrell L; Yossuck P
Ther Drug Monit; 2017 Dec; 39(6):640-647. PubMed ID: 28937537
[TBL] [Abstract][Full Text] [Related]
17. The Association Between Antenatal Maternal Self-reported Substance Use, Maternal Characteristics, and Obstetrical Variables.
Berra A; Kamo S; Mohnot S; Rosselot J; Suire A; Stafford J; Hagan J; Stafford I
J Addict Med; 2019; 13(6):464-469. PubMed ID: 31033670
[TBL] [Abstract][Full Text] [Related]
18. Estimates of illicit drug use during pregnancy by maternal interview, hair analysis, and meconium analysis.
Ostrea EM; Knapp DK; Tannenbaum L; Ostrea AR; Romero A; Salari V; Ager J
J Pediatr; 2001 Mar; 138(3):344-8. PubMed ID: 11241040
[TBL] [Abstract][Full Text] [Related]
19. Mortality within the first 2 years in infants exposed to cocaine, opiate, or cannabinoid during gestation.
Ostrea EM; Ostrea AR; Simpson PM
Pediatrics; 1997 Jul; 100(1):79-83. PubMed ID: 9200364
[TBL] [Abstract][Full Text] [Related]
20. [Prenatal exposure to drugs of abuse using meconium analysis in a low socioeconomic population in Barcelona].
García-Algar O; Vall Combelles O; Puig Sola C; Mur Sierra A; Scaravelli G; Pacifici R; Monleón Getino T; Pichini S
An Pediatr (Barc); 2009 Feb; 70(2):151-8. PubMed ID: 19217571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
